STAT3 and pulmonary hypertension: Finally, there are a number of ways that identified MDSC and T cell populations may contribute to pulmonary hypertension through many of the previously discussed metabolic or signaling pathways, including Arg1, iNOS, STAT3, and PD-L1/2 activation [151].